Fig. 3From: Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patientsThe relative level of microRNAs (mean fold change) during the neoadjuvant chemotherapy (NAC) in breast cancer patients. Plasma levels of microRNAs were determined by RT-qPCR in the plasma of 45 NAC-treated patients. Comparisons between the initial and subsequent time points were calculated using the Wilcoxon testsBack to article page